Pharmaceutical companies, including Pfizer, enter telehealth for direct-to-consumer sales, aiming to lower costs and enhance access.

Pharmaceutical companies like Pfizer are shifting towards direct-to-consumer sales by entering the telehealth sector. This strategy aims to eliminate intermediaries, potentially lowering prescription drug costs and improving patient access to medications. As these initiatives evolve, they could significantly alter the traditional pharmaceutical distribution model and impact the overall healthcare landscape.

September 01, 2024
3 Articles

Further Reading